JANSSEN-CILAG AKTIEBOLAG
556024-0037ActiveDeveloping and delivering transformational pharmaceutical treatments for complex diseases globally.
Pharmaceutical Subsidiaryjnj.com
Oversigt
- 100–199
- Medarbejdere
- 1–5mia SEK
- Omsætning
- 1972
- Grundlagt
Nøglebeslutningstagere
Joaquin Duato
Chairman and Chief Executive Officer
John C. Reed, M.D., Ph.D.
Executive Vice President, Innovative Medicine, R&D
John C. Reed
Executive Vice President, Innovative Medicine, R&D
Eugene A. Woods
Board Member
+37 flere kontakter i Funnelfeedr
Beskrivelse
Janssen-Cilag Aktiebolag operates as a key subsidiary within Johnson & Johnson's Innovative Medicine sector. This division is dedicated to leading where medicine is going, focusing on rigorous science and compassion to address complex diseases. The organization develops and delivers transformational...
JANSSEN-CILAG AS